Our topical GHK-Cu is differentiated due to the prescription peptide formulated to a milligram spec the same dosing standard we apply to Sermorelin and the rest of the Live Enhanced peptide line
Individual results vary considerably
In a single-arm trial from Western Uganda examining the efficacy and safety of an oral bitter leaf infusion in patients aged 12 years and over with uncomplicated malaria, bitter leaf was associated with an adequate clinical response after 2 weeks of treatment in 67% of cases, as well as reduced parasitemia by 32%
Users maintaining excellent sun protection, adequate moisturization, healthy diet supporting collagen synthesis (adequate protein, vitamin C, copper from foods), sufficient sleep, stress management, and avoidance of collagen-damaging habits (smoking, excessive alcohol) preserve treatment gains better than users with suboptimal skincare and lifestyle creating ongoing skin stress overwhelming GHK-Cu induced improvements
Antimicrobial resistance